Pharmacokinetics and Safety of BI 201335 in Patients With Mild to Severe Renal Impairment
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to investigate the influence of mild, moderate and severe
renal impairment on the pharmacokinetics and safety of BI 201335 in comparison to a control
group with normal renal function after single dose of BI 201335.